

Type
Blood Testing
Biomarkers
1
Duration
15 min
Results
3 days
Sample
Blood (venous)
What's included
4 deliverables in this treatment
- Anti-Müllerian Hormone (AMH) quantitative blood assay
- Age-referenced result interpretation with normal range context
- Can be taken any day of the menstrual cycle — no cycle timing needed
- Digital results within 2–4 business days
An Anti-Müllerian Hormone (AMH) blood test that measures a woman's remaining ovarian reserve — the number of viable eggs available in the ovaries. Available at 710 Kč via cz.unilabs.online, collected at any Prague Unilabs collection point, with results within 2–4 business days. AMH is produced directly by growing ovarian follicles and is the most accurate single blood marker for ovarian reserve: higher levels indicate more follicles remaining, while declining AMH signals diminishing egg count as natural fertility decreases with age. The test can be taken at any point in the menstrual cycle. Normal AMH varies significantly with age: 2–2.5 ng/mL is the reference midpoint; healthy women under 30 typically fall in the 1.2–9 ng/mL range; over 30, the reference range is 0.4–6.5 ng/mL. Very high values may indicate polycystic ovarian syndrome (PCOS). Rated 4.85/5 from 171 reviews.
About this treatment
Anti-Müllerian Hormone (AMH) is secreted by the granulosa cells of small antral ovarian follicles — the pool of follicles actively maturing toward possible ovulation. Unlike FSH (which fluctuates with the menstrual cycle) and antral follicle count on ultrasound (which requires specialist imaging), AMH is stable throughout the menstrual cycle, can be measured in a single blood draw on any day of the month, and provides a direct, quantitative indicator of…
The clinical applications of AMH are broad and the test has become one of the most commonly requested fertility-adjacent markers in Czech private healthcare:
Fertility planning: Women considering delaying childbearing who want to understand their biological 'reproductive window' use AMH as an objective data point. A markedly low AMH in a woman in her early thirties warrants earlier fertility consultation than she might otherwise have sought.
Good to know
- Price
- 710 Kč
- Turnaround
- 2–4 business days
- Cycle timing
- Any day — no scheduling needed
- Rating
- 4.85/5 (171 reviews)
Who is this for?
Women 25–42 assessing fertility status, planning egg freezing, being evaluated for IVF, investigating PCOS, or simply wanting to understand their ovarian reserve
Preparation required
No fasting required. Can be performed on any day of the menstrual cycle. No other special preparation needed.
Panel categories
Biomarkers tested
1A hormone secreted by cells in developing egg sacs (follicles), indicating ovarian reserve.
About the clinic
Reviews, team and credentials
Independent review links and clinic-reported team information.
11,172 clinic reviews
From independent platforms
Clinical team
Unilabs CZ employs over 1,450 staff across its laboratory network, including board-certified specialists in clinical biochemistry, haematology, immunology, microbiology, pathology, and forensic genetics. All laboratory operations are supervised by qualified laboratory physicians (atestovaní lékaři) under the Czech Ministry of Health's accreditation framework. The Prague client centre at Hadovka (Praha 6 – Evropská)…
Languages: Czech
What clients say
"{"author":"Verified customer — Thyroid Panel (cz.unilabs.online)","text":"Vše proběhlo rychle a profesionálně. Výsledky jsem měla do 2 dnů a online interpretace mi vše srozumitelně vysvětlila.","rating":5}"
"{"author":"Verified customer — Women's Prevention Panel (cz.unilabs.online)","text":"Objednání přes e-shop bylo jednoduché, odběr proběhl bez čekání, výsledky přišly rychle. Rozhodně doporučuji.","rating":5}"
Treatment highlights
- Anti-Müllerian Hormone (AMH) quantitative blood assay
- Age-referenced result interpretation with normal range context
+2 more items in What's included
710 Kč per test. Single blood draw. Results within 2–4 business days. Optional uLékaře.cz interpretation 495 Kč.
